A modern Safran Risk alternative

It would be wrong to underrate Safran Risk. Its integrated schedule-and-cost Monte Carlo is a reference-grade implementation: it models three-point and many-parameter distributions, correlates durations and costs, runs risk registers against the network, and produces joint confidence level curves that let an owner read schedule and cost contingency together rather than as two separate analyses. That tight cost-schedule integration and its JCL output are among the strongest in the category.

Its methodology lineage matters too. Safran Risk is closely associated with the QSRA practices David Hulett and the wider AACE community codified, and it carries the forensic, owner- and regulator-grade reputation that megaproject practitioners trust. For an EPC, energy, or large-defense analyst who needs deep correlated cost-and-schedule risk in front of a board, that maturity is a legitimate advantage a newer tool must respect rather than dismiss. CritPath competes on fit, modernity, and breadth of method — not by claiming Safran's engine is weak.

The gaps are structural, not cosmetic. Safran Risk is sold quote-only as part of an enterprise project-controls suite, is desktop/Windows-oriented, and assumes a dedicated analyst drives the model and exports a static report — there is no self-serve, team-wide web workflow. Its world model is construction and megaproject delivery: activities, calendars, correlated cost risk, with no concept of the methods R&D programs lean on hardest.

Specifically, Safran Risk has no Critical Chain Project Management, no Theory of Constraints or Drum-Buffer-Rope, no decision gates, and no WSJF or Cost of Delay. Its AI story is an external pre-step, not a copilot that reasons over the live dependency graph. For a biotech program where a CMC vendor slip should re-cascade the entire plan, or a deep-tech team gating on a TRL milestone with investor dates attached, those are exactly the techniques and the schedule-aware reasoning that matter — and exactly what a megaproject-shaped QSRA tool was never built to carry.

CritPath AI keeps the probabilistic rigor and modernizes everything around it. Its Monte Carlo engine runs PERT-Beta distributions with risk-event injection, criticality index, tornado sensitivity, optional duration correlation, and P50/P80/P90 finish dates — the risk-driven core Safran users expect. On top of that it layers a full Critical Path Method (four dependency types, lag, float, near-critical analysis), CCPM with Theory of Constraints and Drum-Buffer-Rope (drum, project and feeding buffers, fever chart), decision gates with retroactive rescheduling, WSJF and Cost of Delay, and EVM (SPI/CPI/EAC).

All of it carries AACE RP 132R-23 Level 4 risk-driven scheduling with an append-only audit log, and all of it runs in a browser with multi-tenant orgs, 2FA, and XLSX/CSV import. The differentiator Safran cannot match is the AI copilot: built on Claude and Gemini and grounded in your actual dependency graph, it can tell you which task is driving your P80 slip and what a gate decision does downstream — reasoning over the real engine, not a separate AI pre-processing pass. CritPath does not yet match Safran's correlated cost-risk and JCL depth on megaproject cost contingency; it wins on R&D fit, modern collaborative UX, method breadth, and grounded AI.

The table below compares the two on the capabilities that decide an R&D schedule-risk purchase. Safran Risk figures are approximate and orientation-only; it is sold quote-only as part of an enterprise suite, so no public per-seat price is published.

If you are a project-controls analyst on an energy, infrastructure, or large-defense megaproject and you need deep, correlated cost-and-schedule Monte Carlo with joint confidence level curves in front of an owner, Safran Risk's integrated engine and AACE-aligned pedigree are a legitimate reason to stay. CritPath does not claim to out-forensics Safran on correlated cost contingency on its home turf today.

But if you run R&D programs and want probabilistic dates plus CCPM buffers, TOC constraints, and decision gates that re-cascade the schedule — accessible to a whole program team in a browser, with an AI copilot that explains why a date moved — CritPath AI occupies a quadrant Safran cannot reach. You get AACE-grade risk-driven scheduling without a quote-only enterprise deal, an analyst bottleneck, or a desktop-bound megaproject tool, at $10/user/month with AI usage billed separately by metered token cost.